GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Thoratec Corp (FRA:TL1) » Definitions » E10

Thoratec (FRA:TL1) E10 : €0.00 (As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Thoratec E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Thoratec's adjusted earnings per share data for the three months ended in Jun. 2015 was €0.214. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Jun. 2015.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-09), Thoratec's current stock price is €55.92. Thoratec's E10 for the quarter that ended in Jun. 2015 was €0.00. Thoratec's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Thoratec was 140.92. The lowest was 35.80. And the median was 70.53.


Thoratec E10 Historical Data

The historical data trend for Thoratec's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thoratec E10 Chart

Thoratec Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.40 0.50 0.65 0.81

Thoratec Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.75 0.81 0.87 -

Competitive Comparison of Thoratec's E10

For the Medical Devices subindustry, Thoratec's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thoratec's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Thoratec's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Thoratec's Shiller PE Ratio falls into.



Thoratec E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thoratec's adjusted earnings per share data for the three months ended in Jun. 2015 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2015 (Change)*Current CPI (Jun. 2015)
=0.214/100.6839*100.6839
=0.214

Current CPI (Jun. 2015) = 100.6839.

Thoratec Quarterly Data

per share eps CPI Adj_EPS
200509 0.049 83.876 0.059
200512 0.072 83.032 0.087
200603 -0.017 84.298 -0.020
200606 0.008 85.606 0.009
200609 0.024 85.606 0.028
200612 0.045 85.142 0.053
200703 -0.008 86.640 -0.009
200706 0.015 87.906 0.017
200709 -0.022 87.964 -0.025
200712 0.043 88.616 0.049
200803 -0.006 90.090 -0.007
200806 0.096 92.320 0.105
200809 0.084 92.307 0.092
200812 0.073 88.697 0.083
200903 0.077 89.744 0.086
200906 0.021 91.003 0.023
200909 0.137 91.120 0.151
200912 0.110 91.111 0.122
201003 0.155 91.821 0.170
201006 0.221 91.962 0.242
201009 0.183 92.162 0.200
201012 0.136 92.474 0.148
201103 0.193 94.283 0.206
201106 0.250 95.235 0.264
201109 0.211 95.727 0.222
201112 0.194 95.213 0.205
201203 0.326 96.783 0.339
201206 0.279 96.819 0.290
201209 0.318 97.633 0.328
201212 -0.188 96.871 -0.195
201303 0.239 98.209 0.245
201306 0.303 98.518 0.310
201309 0.239 98.790 0.244
201312 0.164 98.326 0.168
201403 0.231 99.695 0.233
201406 0.221 100.560 0.221
201409 0.039 100.428 0.039
201412 0.174 99.070 0.177
201503 0.185 99.621 0.187
201506 0.214 100.684 0.214

Add all the adjusted EPS together and divide 10 will get our e10.


Thoratec  (FRA:TL1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Thoratec was 140.92. The lowest was 35.80. And the median was 70.53.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Thoratec E10 Related Terms

Thank you for viewing the detailed overview of Thoratec's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Thoratec (FRA:TL1) Business Description

Traded in Other Exchanges
N/A
Address
Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. It develops, manufactures and markets proprietary medical devices used for circulatory support. Following the sale of ITC in 2010, the Company has one operating segment: Cardiovascular group. This segment is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. The Company's VAD products primarily serve patients suffering from late-stage HF. HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. Hospitals that perform open heart surgery and heart transplants are the potential customers for its Thoratec and HeartMate products. The Company estimates that it sells into 293 of these centers. According to the Company's estimates, it is in approximately 149 centers in the United States and 144 centers internationally. Competition from medical device companies and medical device divisions of healthcare companies, pharmaceutical companies and gene- and cell-based therapies is intense and is expected to increase. It therefore continues to expect new competitors both from the pharmacological and the medical device space. Among the medical device competitors are Aachen Innovative Solutions GmbH, AbioMed, Inc., Berlin Heart GmbH, HeartWare International Inc., Jarvik Heart, Inc., Maquet Cardiovascular, LLC (a division of Getinge AB), MicroMed Technology, Inc., Sun Medical Technology Research Corporation, SynCardia Systems, Inc., and Terumo Heart, Inc. All of the Company's proposed products will require regulatory approval prior to commercialization. In particular, medical devices are subject to rigorous pre-clinical testing as a condition of approval by the FDA and by similar authorities in foreign countries.

Thoratec (FRA:TL1) Headlines

No Headlines